About 4-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-(2-hydroxyethyl)benzamide;4-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-(2-methoxyethyl)benzamide;1-(1,3-benzothiazol-2-yl)-3-N-(4-methoxyphenyl)-1,2,4-triazole-3,5-diamine;1-[6-(4-cyclopropylpiperazin-1-yl)pyrimidin-4-yl]-3-N-[4-(1-propan-2-ylpiperidin-4-yl)phenyl]-1,2,4-triazole-3,5-diamine
4-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-(2-hydroxyethyl)benzamide;4-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-(2-methoxyethyl)benzamide;1-(1,3-benzothiazol-2-yl)-3-N-(4-methoxyphenyl)-1,2,4-triazole-3,5-diamine;1-[6-(4-cyclopropylpiperazin-1-yl)pyrimidin-4-yl]-3-N-[4-(1-propan-2-ylpiperidin-4-yl)phenyl]-1,2,4-triazole-3,5-diamine (PubChem CID 160930217) has the molecular formula C76H88N30O5S
and a molecular weight of 1533.81 g/mol. Its IUPAC name is 4-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-(2-hydroxyethyl)benzamide;4-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-(2-methoxyethyl)benzamide;1-(1,3-benzothiazol-2-yl)-3-N-(4-methoxyphenyl)-1,2,4-triazole-3,5-diamine;1-[6-(4-cyclopropylpiperazin-1-yl)pyrimidin-4-yl]-3-N-[4-(1-propan-2-ylpiperidin-4-yl)phenyl]-1,2,4-triazole-3,5-diamine.
Frequently Asked Questions
What is the IUPAC name of 4-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-(2-hydroxyethyl)benzamide;4-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-(2-methoxyethyl)benzamide;1-(1,3-benzothiazol-2-yl)-3-N-(4-methoxyphenyl)-1,2,4-triazole-3,5-diamine;1-[6-(4-cyclopropylpiperazin-1-yl)pyrimidin-4-yl]-3-N-[4-(1-propan-2-ylpiperidin-4-yl)phenyl]-1,2,4-triazole-3,5-diamine?
The IUPAC name of 4-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-(2-hydroxyethyl)benzamide;4-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-(2-methoxyethyl)benzamide;1-(1,3-benzothiazol-2-yl)-3-N-(4-methoxyphenyl)-1,2,4-triazole-3,5-diamine;1-[6-(4-cyclopropylpiperazin-1-yl)pyrimidin-4-yl]-3-N-[4-(1-propan-2-ylpiperidin-4-yl)phenyl]-1,2,4-triazole-3,5-diamine (CID 160930217) is 4-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-(2-hydroxyethyl)benzamide;4-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-(2-methoxyethyl)benzamide;1-(1,3-benzothiazol-2-yl)-3-N-(4-methoxyphenyl)-1,2,4-triazole-3,5-diamine;1-[6-(4-cyclopropylpiperazin-1-yl)pyrimidin-4-yl]-3-N-[4-(1-propan-2-ylpiperidin-4-yl)phenyl]-1,2,4-triazole-3,5-diamine.
What is the SMILES notation for 4-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-(2-hydroxyethyl)benzamide;4-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-(2-methoxyethyl)benzamide;1-(1,3-benzothiazol-2-yl)-3-N-(4-methoxyphenyl)-1,2,4-triazole-3,5-diamine;1-[6-(4-cyclopropylpiperazin-1-yl)pyrimidin-4-yl]-3-N-[4-(1-propan-2-ylpiperidin-4-yl)phenyl]-1,2,4-triazole-3,5-diamine?
The canonical SMILES for 4-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-(2-hydroxyethyl)benzamide;4-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-(2-methoxyethyl)benzamide;1-(1,3-benzothiazol-2-yl)-3-N-(4-methoxyphenyl)-1,2,4-triazole-3,5-diamine;1-[6-(4-cyclopropylpiperazin-1-yl)pyrimidin-4-yl]-3-N-[4-(1-propan-2-ylpiperidin-4-yl)phenyl]-1,2,4-triazole-3,5-diamine is CC(C)N1CCC(c2ccc(Nc3nc(N)n(-c4cc(N5CCN(C6CC6)CC5)ncn4)n3)cc2)CC1.COCCNC(=O)c1ccc(Nc2nc(N)n(-c3ccccn3)n2)cc1.COc1ccc(Nc2nc(N)n(-c3nc4ccccc4s3)n2)cc1.Nc1nc(Nc2ccc(C(=O)NCCO)cc2)nn1-c1ccccn1.
What is the InChIKey of 4-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-(2-hydroxyethyl)benzamide;4-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-(2-methoxyethyl)benzamide;1-(1,3-benzothiazol-2-yl)-3-N-(4-methoxyphenyl)-1,2,4-triazole-3,5-diamine;1-[6-(4-cyclopropylpiperazin-1-yl)pyrimidin-4-yl]-3-N-[4-(1-propan-2-ylpiperidin-4-yl)phenyl]-1,2,4-triazole-3,5-diamine?
The InChIKey is STDYFVABTVHROV-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H38N10.C17H19N7O2.C16H17N7O2.C16H14N6OS/c1-19(2)34-11-9-21(10-12-34)20-3-5-22(6-4-20)31-27-32-26(28)37(33-27)25-17-24(29-18-30-25)36-15-13-35(14-16-36)23-7-8-23;1-26-11-10-20-15(25)12-5-7-13(8-6-12)21-17-22-16(18)24(23-17)14-4-2-3-9-19-14;17-15-21-16(22-23(15)13-3-1-2-8-18-13)20-12-6-4-11(5-7-12)14(25)19-9-10-24;1-23-11-8-6-10(7-9-11)18-15-20-14(17)22(21-15)16-19-12-4-2-3-5-13(12)24-16/h3-6,17-19,21,23H,7-16H2,1-2H3,(H3,28,31,32,33);2-9H,10-11H2,1H3,(H,20,25)(H3,18,21,22,23);1-8,24H,9-10H2,(H,19,25)(H3,17,20,21,22);2-9H,1H3,(H3,17,18,20,21).
What are the key properties of 4-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-(2-hydroxyethyl)benzamide;4-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-(2-methoxyethyl)benzamide;1-(1,3-benzothiazol-2-yl)-3-N-(4-methoxyphenyl)-1,2,4-triazole-3,5-diamine;1-[6-(4-cyclopropylpiperazin-1-yl)pyrimidin-4-yl]-3-N-[4-(1-propan-2-ylpiperidin-4-yl)phenyl]-1,2,4-triazole-3,5-diamine?
4-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-(2-hydroxyethyl)benzamide;4-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-(2-methoxyethyl)benzamide;1-(1,3-benzothiazol-2-yl)-3-N-(4-methoxyphenyl)-1,2,4-triazole-3,5-diamine;1-[6-(4-cyclopropylpiperazin-1-yl)pyrimidin-4-yl]-3-N-[4-(1-propan-2-ylpiperidin-4-yl)phenyl]-1,2,4-triazole-3,5-diamine has a molecular weight of 1533.81 g/mol, XLogP of 8.54, 24 rotatable bonds, 11 hydrogen bond donors, and 34 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-(2-hydroxyethyl)benzamide;4-[(5-amino-1-pyridin-2-yl-1,2,4-triazol-3-yl)amino]-N-(2-methoxyethyl)benzamide;1-(1,3-benzothiazol-2-yl)-3-N-(4-methoxyphenyl)-1,2,4-triazole-3,5-diamine;1-[6-(4-cyclopropylpiperazin-1-yl)pyrimidin-4-yl]-3-N-[4-(1-propan-2-ylpiperidin-4-yl)phenyl]-1,2,4-triazole-3,5-diamine is sourced from PubChem (CID 160930217), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).